Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lactobacillus paracasei MSMC 39-1 vs topical corticosteroid in mild chronic plaque psoriasis
TCTR20250227004Phase 2Completed
- Sponsor
- Strategic Wisdom and Research Institute
- Start
- Jan 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of Lactobacillus paracasei MSMC 39-1 in psoriasis (2 arms), sponsored by Strategic Wisdom and Research Institute. Started Jan 2025; status: completed.
02
Drugs
Lactobacillus paracasei MSMC 39-1
03
Conditions
psoriasis
Beyond the preview
Go deeper on TCTR20250227004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250227004.